ELAN IMPORTANT DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Elanco Animal Health Incorporated Investors to Secure Counsel Before Important December 6 Deadline in Securities Class Action – ELAN

NEW YORK, Nov. 22, 2024 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Elanco Animal Health Incorporated (NYSE: ELAN) between November 7, 2023 and June 26, 2024, both dates inclusive (the “Class Period”), of the important December 6, 2024 lead plaintiff deadline. SO WHAT: If you purchased Elanco […]

Continue Reading

LLAP DEADLINE ALERT: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Terran Orbital Corporation Investors to Secure Counsel Before Important November 26 Deadline in Securities Class Action – LLAP

NEW YORK, Nov. 22, 2024 (GLOBE NEWSWIRE) —WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Terran Orbital Corporation (NYSE: LLAP) between August 15, 2023 and August 14, 2024, both dates inclusive (the “Class Period”), of the important November 26, 2024 lead plaintiff deadline. SO WHAT: If you purchased Terran securities during […]

Continue Reading

POWW IMPORTANT DEADLINE: ROSEN, SKILLED INVESTOR COUNSEL, Encourages AMMO, Inc. Investors to Secure Counsel Before Important November 29 Deadline in Securities Class Action – POWW

NEW YORK, Nov. 22, 2024 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of AMMO, Inc. (NASDAQ: POWW) between August 19, 2020 and September 24, 2024, both dates inclusive (the “Class Period”), of the important November 29, 2024 lead plaintiff deadline. SO WHAT: If you purchased AMMO securities during […]

Continue Reading

MGX DEADLINE MONDAY: ROSEN, A TOP RANKED LAW FIRM, Encourages Metagenomi, Inc. Investors to Secure Counsel Before Important November 25 Deadline in Securities Class Action – MGX

NEW YORK, Nov. 22, 2024 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of stock of Metagenomi, Inc. (NASDAQ: MGX) pursuant and/or traceable to the Company’s initial public offering conducted between February 9 and 13, 2024 (the “IPO”), of the important November 25, 2024 lead plaintiff deadline. SO WHAT: If you […]

Continue Reading